Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
CNY 7.84
(0.38%)
CNY 7.84
(0.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.07 Billion CNY | -33.78% |
| 2022 | 1.62 Billion CNY | -30.39% |
| 2021 | 2.33 Billion CNY | 25.68% |
| 2020 | 1.85 Billion CNY | -0.52% |
| 2019 | 1.86 Billion CNY | 81.11% |
| 2018 | 1.02 Billion CNY | -2.12% |
| 2017 | 1.05 Billion CNY | 127.2% |
| 2016 | 462.86 Million CNY | 55.21% |
| 2015 | 298.21 Million CNY | -22.79% |
| 2014 | 386.23 Million CNY | 32.22% |
| 2013 | 292.11 Million CNY | 131.74% |
| 2012 | 126.05 Million CNY | 161.97% |
| 2011 | 48.11 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.44 Billion CNY | 9.07% |
| 2024 Q3 | 1.41 Billion CNY | -2.18% |
| 2024 Q1 | 1.32 Billion CNY | 23.24% |
| 2023 FY | 1.07 Billion CNY | -33.78% |
| 2023 Q3 | 1.41 Billion CNY | -5.75% |
| 2023 Q4 | 1.07 Billion CNY | -23.96% |
| 2023 Q2 | 1.49 Billion CNY | -14.26% |
| 2023 Q1 | 1.74 Billion CNY | 7.77% |
| 2022 Q3 | 2.31 Billion CNY | -3.73% |
| 2022 FY | 1.62 Billion CNY | -30.39% |
| 2022 Q4 | 1.62 Billion CNY | -29.84% |
| 2022 Q2 | 2.4 Billion CNY | 19.28% |
| 2022 Q1 | 2.01 Billion CNY | -13.59% |
| 2021 Q4 | 2.33 Billion CNY | 3.56% |
| 2021 FY | 2.33 Billion CNY | 25.68% |
| 2021 Q1 | 2.41 Billion CNY | 30.4% |
| 2021 Q2 | 2.19 Billion CNY | -9.17% |
| 2021 Q3 | 2.25 Billion CNY | 2.46% |
| 2020 Q4 | 1.85 Billion CNY | 0.66% |
| 2020 Q1 | 1.9 Billion CNY | 2.28% |
| 2020 Q2 | 1.82 Billion CNY | -4.41% |
| 2020 Q3 | 1.84 Billion CNY | 1.08% |
| 2020 FY | 1.85 Billion CNY | -0.52% |
| 2019 FY | 1.86 Billion CNY | 81.11% |
| 2019 Q3 | 1.85 Billion CNY | 14.43% |
| 2019 Q2 | 1.61 Billion CNY | -2.41% |
| 2019 Q4 | 1.86 Billion CNY | 0.6% |
| 2019 Q1 | 1.65 Billion CNY | 61.21% |
| 2018 Q4 | 1.02 Billion CNY | 0.77% |
| 2018 FY | 1.02 Billion CNY | -2.12% |
| 2018 Q3 | 1.02 Billion CNY | -1.64% |
| 2018 Q2 | 1.03 Billion CNY | -3.11% |
| 2018 Q1 | 1.07 Billion CNY | 1.91% |
| 2017 Q4 | 1.05 Billion CNY | 160.75% |
| 2017 Q1 | 411.36 Million CNY | -11.13% |
| 2017 Q2 | 403.51 Million CNY | -1.91% |
| 2017 Q3 | 403.3 Million CNY | -0.05% |
| 2017 FY | 1.05 Billion CNY | 127.2% |
| 2016 Q4 | 462.86 Million CNY | 226.47% |
| 2016 FY | 462.86 Million CNY | 55.21% |
| 2016 Q2 | 331.91 Million CNY | 19.57% |
| 2016 Q3 | 141.77 Million CNY | -57.29% |
| 2016 Q1 | 277.58 Million CNY | -6.92% |
| 2015 Q2 | 397.68 Million CNY | 0.0% |
| 2015 Q4 | 298.21 Million CNY | -4.08% |
| 2015 Q3 | 310.88 Million CNY | -21.82% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 298.21 Million CNY | -22.79% |
| 2014 Q4 | 386.23 Million CNY | 0.0% |
| 2014 FY | 386.23 Million CNY | 32.22% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 292.11 Million CNY | 131.74% |
| 2012 FY | 126.05 Million CNY | 161.97% |
| 2011 FY | 48.11 Million CNY | 0.0% |